PIONEER REAL

Projekt

PIONEER REAL

Automatisch geschlossen · 2020 bis 2022

Bilz Stefan, Drescher Tilman, Grillmayr Victoria, Räss Andrea

Art

Klinische Forschung

Reichweite

Multizentrisch, KSSG als teilnehmendes Zentrum

Bereiche

Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen

Status

Automatisch geschlossen

Start

2020

Ende

2022

Finanzierungsart

Industrie

Studiendesign

A multi-centre, prospective, non-interventional single-arm study investigating clinical parameters associated with the use of once-daily oral semaglutide in a real-world adult population with type 2 diabetes in Switzerland

Kurzbeschreibung/Zielsetzung

The primary objective is to investigate the glycaemic control in adult
patients with type 2 diabetes (T2D) who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.

The secondary objective is to investigate mean change in body
weight in adult patients with T2D who have not previously been
treated with injectable glucose-lowering medication and who initiate
treatment with oral semaglutide according to local clinical practice.